Junshi Biosciences Announces Acceptance by NMPA of its IND Application for JS006

    NEXT STORY
    Amarin Files Patent Infringement Lawsuit Against Hikma
    PREV STORY
    Skylight Health Reports Q3 Results Achieving Consecutive Quarter and YTD Positive Adjusted EBITDA
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cesca Therapeutics Inc. Announces Release of X-Mini™ Cell Selection Kit for the CAR-T Research Market

    RANCHO CORDOVA, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL), ...

    author_avatar
    NASDAQ Market News

    Heat Biologics Reports Update on Its HS-410 Phase 2 Bladder Cancer Trial

    The company anticipates clinical timelines for HS-410 to remain materially unchangedDURHAM, N.C., Feb. 03, ...

    author_avatar
    NASDAQ Market News

    Sentia Medical Sciences Inc. Appoints Dr. Yvette Taché as Chair of the Scientific Advisory Board and Announces Award of a Phase 1 Small Business Innovation Research (SBIR) Grant to Develop Astressins for the Treatment of Irritable Bowel Syndrome (IBS)

    SAN DIEGO, June 12, 2018 (GLOBE NEWSWIRE) -- Sentia announced today the appointment of ...

    author_avatar
    NASDAQ Market News